Top 20 Pharmaceutical Companies
based on 2012 pharma revenues
1
Pfizer$51,214
(prev.: 1)
2
Novartis$46,732
(prev.: 2)
3
Merck$40,601
(prev.: 4)
4
Sanofi$38,259
(prev.: 3)
5
GlaxoSmithKline$33,787
(prev.: 5)
6
AstraZeneca$27,973
(prev.: 6)
7
Johnson & Johnson$25,351
(prev.: 7)
8
Abbott Laboratories$23,133
(prev.: 9)
9
Eli Lilly & Co.$20,566
(prev.: 8)
10
Teva$18,535
(prev.: 12)
11
Bristol-Myers Squibb$17,621
(prev.: 10)
12
Takeda$16,961
(prev.: 11)
13
Boehringer-Ingelheim$14,665
(prev.: 13)
14
Bayer$13,890
(prev.: 14)
15
Astellas$12,168
(prev.: 15)
16
Daiichi-Sankyo$11,504
(prev.: 16)
17
Otsuka$10,295
(prev.: 17)
18
Gilead$9,398
(prev.: 18)
19
Mylan$6,750
(prev.: 20)
20
EISAI$6,647
(prev.: 19)
- See more at:
http://www.contractpharma.com/issues/2013-07/view_features/top-20-pharma-report-/#sthash.uF7p38FR.dpuf